Neoadjuvant Immunotherapy in Early Stage Non-small-cell Lung Cancer Presenting as Synchronous Ground-glass Nodules
NCT04047186
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Multiple Pulmonary Nodules
Interventions
DRUG:
Tislelizumab Injection
Sponsor
XiangNing Fu